ARCHIVES

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 6 | June 30, 2006

Download PDF Visit The Full Archive

Related Articles

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

November 28, 2003

ASCO, NCCS form cancer quality alliance.

November 11, 2005

Capitol Hill: Trial Results Represent Culmination of Research, Klausner Tells House

March 19, 1999

The New NCI: Structure, Procedures, Advisory Boards To Change, Klausner Says

September 15, 1995

Robert Day Advocates NCI Payment for Investigator Salaries

May 7, 1999

Immunotherapy Demonstrates Disease Control in Phase II Study

September 28, 2012